Check the acquisition promise
Read the store headline, screenshots and description. What problem is the app promising to solve?
Study the storefront ↗02 / Storefront & product
Where the click lands.
Study the product story and store experience behind the acquisition funnel.
Screenshots
03 / Market context
The business behind the app.
Keep revenue, downloads and store rankings separate from advertising performance.
How Much Does 복약 일기 - Drug Diary(드러그 다이어리) Make?
Monthly Revenue
$1.0K
Annualized estimate
$12.0K
Per Download
$1.00
Platform Performance
🍎iOS
Revenue
$1.0K
Downloads
1.0K
Rating Distribution
N/A
☆☆☆☆☆
0 reviews
No rating data available
Version History (16)▼
2.0.182/20/2024
2.0.171/3/2024
2.0.169/13/2023
2.0.159/8/2023
2.0.138/29/2023
2.0.128/22/2023
2.0.115/18/2023
2.0.103/31/2023
2.0.82/15/2023
2.0.71/9/2023
Available In (115 Countries)▼
🇺🇸 United States🇦🇺 Australia🇨🇦 Canada🇨🇳 China🇫🇷 France🇩🇪 Germany🇬🇧 United Kingdom🇮🇹 Italy🇯🇵 Japan🇰🇷 South Korea🇷🇺 Russia🇩🇿 DZ🇦🇴 AO🇦🇷 Argentina🇦🇹 Austria🇦🇿 AZ🇧🇭 BH🇧🇧 BB🇧🇾 BY🇧🇪 Belgium🇧🇲 BM🇧🇷 Brazil🇧🇬 Bulgaria🇨🇱 Chile🇨🇴 Colombia🇨🇷 CR🇭🇷 Croatia🇨🇾 CY🇨🇿 Czech Republic🇩🇰 Denmark🇩🇴 DO🇪🇨 EC🇪🇬 Egypt🇸🇻 SV🇫🇮 Finland🇬🇭 GH🇬🇷 Greece🇬🇹 GT🇭🇰 Hong Kong🇭🇺 Hungary🇮🇳 India🇮🇩 Indonesia🇮🇪 Ireland🇮🇱 Israel🇰🇿 KZ🇰🇪 Kenya🇰🇼 KW🇱🇧 LB🇱🇹 Lithuania🇱🇺 LU🇲🇴 MO🇲🇬 MG🇲🇾 Malaysia🇲🇹 MT🇲🇽 Mexico🇳🇱 Netherlands🇳🇿 New Zealand🇳🇬 Nigeria🇳🇴 Norway🇴🇲 OM🇵🇰 Pakistan🇵🇦 PA🇵🇪 Peru🇵🇭 Philippines🇵🇱 Poland🇵🇹 Portugal🇶🇦 QA🇷🇴 Romania🇸🇦 Saudi Arabia🇷🇸 RS🇸🇬 Singapore🇸🇰 Slovakia🇸🇮 Slovenia🇿🇦 South Africa🇪🇸 Spain🇱🇰 LK🇸🇪 Sweden🇨🇭 Switzerland🇹🇼 Taiwan🇹🇭 Thailand🇹🇳 TN🇹🇷 Turkey🇺🇦 Ukraine🇦🇪 UAE🇺🇾 UY🇺🇿 UZ🇻🇪 VE🇻🇳 Vietnam🇧🇴 BO🇰🇭 KH🇪🇪 Estonia🇱🇻 Latvia🇳🇮 NI🇵🇾 PY🇦🇫 AF🇬🇪 GE🇮🇶 IQ🇱🇾 LY🇲🇦 MA🇲🇿 MZ🇲🇲 MM🇾🇪 YE🇧🇯 BJ🇧🇫 BF🇨🇲 CM🇨🇬 CG🇨🇮 CI🇯🇴 JO🇱🇦 LA🇲🇱 ML🇸🇳 SN🇹🇿 TZ🇺🇬 UG🇿🇲 ZM🇿🇼 ZW
Supported Languages (1)▼
English
App Details▼
복약일기 - Drug Diary 복약관리, 건강 다이어리, 약물 부작용 보고를 한번에! - 약물 복약 관리 기능(약물 등록, 알람) - 혈당, 혈압, 체중 기록, 관리 기능 - 고혈압, 당뇨병 관리를 위한 정보 제공 - 다양한 의약품과 약물 부작용에 대한 정보 제공...
iOS App ID
6443573631
Content Rating
12+
Min OS
11.0
Size
294.0 MB
Publisher
HERINGS inc.
